• Something wrong with this record ?

High dietary advanced glycation end products are associated with poorer spatial learning and accelerated Aβ deposition in an Alzheimer mouse model

I. Lubitz, J. Ricny, D. Atrakchi-Baranes, C. Shemesh, E. Kravitz, S. Liraz-Zaltsman, A. Maksin-Matveev, I. Cooper, A. Leibowitz, J. Uribarri, J. Schmeidler, W. Cai, Z. Kristofikova, D. Ripova, D. LeRoith, M. Schnaider-Beeri,

. 2016 ; 15 (2) : 309-16. [pub] 20160119

Language English Country England, Great Britain

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc17014152

There is growing evidence of the involvement of advanced glycation end products (AGEs) in the pathogenesis of neurodegenerative processes including Alzheimer's disease (AD) and their function as a seed for the aggregation of Aβ, a hallmark feature of AD. AGEs are formed endogenously and exogenously during heating and irradiation of foods. We here examined the effect of a diet high in AGEs in the context of an irradiated diet on memory, insoluble Aβ42 , AGEs levels in hippocampus, on expression of the receptor for AGEs (RAGE), and on oxidative stress in the vasculature. We found that AD-like model mice on high-AGE diet due to irradiation had significantly poorer memory, higher hippocampal levels of insoluble Aβ42 and AGEs as well as higher levels of oxidative stress on vascular walls, compared to littermates fed an isocaloric diet. These differences were not due to weight gain. The data were further supported by the overexpression of RAGE, which binds to Aβ42 and regulates its transport across the blood-brain barrier, suggesting a mediating pathway. Because exposure to AGEs can be diminished, these insights provide an important simple noninvasive potential therapeutic strategy for alleviating a major lifestyle-linked disease epidemic.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17014152
003      
CZ-PrNML
005      
20240502090323.0
007      
ta
008      
170413s2016 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/acel.12436 $2 doi
035    __
$a (PubMed)26781037
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Lubitz, Irit $u The Joseph Sagol Neuroscience Center Tel Hashomer, Ramat Gan, 52621, Israel.
245    10
$a High dietary advanced glycation end products are associated with poorer spatial learning and accelerated Aβ deposition in an Alzheimer mouse model / $c I. Lubitz, J. Ricny, D. Atrakchi-Baranes, C. Shemesh, E. Kravitz, S. Liraz-Zaltsman, A. Maksin-Matveev, I. Cooper, A. Leibowitz, J. Uribarri, J. Schmeidler, W. Cai, Z. Kristofikova, D. Ripova, D. LeRoith, M. Schnaider-Beeri,
520    9_
$a There is growing evidence of the involvement of advanced glycation end products (AGEs) in the pathogenesis of neurodegenerative processes including Alzheimer's disease (AD) and their function as a seed for the aggregation of Aβ, a hallmark feature of AD. AGEs are formed endogenously and exogenously during heating and irradiation of foods. We here examined the effect of a diet high in AGEs in the context of an irradiated diet on memory, insoluble Aβ42 , AGEs levels in hippocampus, on expression of the receptor for AGEs (RAGE), and on oxidative stress in the vasculature. We found that AD-like model mice on high-AGE diet due to irradiation had significantly poorer memory, higher hippocampal levels of insoluble Aβ42 and AGEs as well as higher levels of oxidative stress on vascular walls, compared to littermates fed an isocaloric diet. These differences were not due to weight gain. The data were further supported by the overexpression of RAGE, which binds to Aβ42 and regulates its transport across the blood-brain barrier, suggesting a mediating pathway. Because exposure to AGEs can be diminished, these insights provide an important simple noninvasive potential therapeutic strategy for alleviating a major lifestyle-linked disease epidemic.
650    _2
$a Alzheimerova nemoc $x metabolismus $7 D000544
650    _2
$a amyloidní beta-protein $x metabolismus $7 D016229
650    _2
$a zvířata $7 D000818
650    _2
$a dieta $7 D004032
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a produkty pokročilé glykace $x aplikace a dávkování $x metabolismus $7 D017127
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a náhodné rozdělení $7 D011897
650    _2
$a prostorové učení $x fyziologie $7 D065853
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Ricny, Jan $u Department of Biochemistry and Brain Pathophysiology, National Institute of Mental Health, Topolova 748, Klecany, 250 67, Czech Republic.
700    1_
$a Atrakchi-Baranes, Dana $u The Joseph Sagol Neuroscience Center Tel Hashomer, Ramat Gan, 52621, Israel. $7 gn_A_00009816
700    1_
$a Shemesh, Chen $u The Joseph Sagol Neuroscience Center Tel Hashomer, Ramat Gan, 52621, Israel.
700    1_
$a Kravitz, Efrat $u The Joseph Sagol Neuroscience Center Tel Hashomer, Ramat Gan, 52621, Israel.
700    1_
$a Liraz-Zaltsman, Sigal $u The Joseph Sagol Neuroscience Center Tel Hashomer, Ramat Gan, 52621, Israel.
700    1_
$a Maksin-Matveev, Anna $u The Joseph Sagol Neuroscience Center Tel Hashomer, Ramat Gan, 52621, Israel.
700    1_
$a Cooper, Itzik $u The Joseph Sagol Neuroscience Center Tel Hashomer, Ramat Gan, 52621, Israel.
700    1_
$a Leibowitz, Avshalom $u Department of Internal Medicine D and Hypertension Unit, Sheba Medical Center, Ramat Gan, 52621, Israel.
700    1_
$a Uribarri, Jaime $u Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, 10029, USA.
700    1_
$a Schmeidler, James $u Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, 10029, USA.
700    1_
$a Cai, Weijing $u Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, 10029, USA.
700    1_
$a Kristofikova, Zdena $u Department of Biochemistry and Brain Pathophysiology, National Institute of Mental Health, Topolova 748, Klecany, 250 67, Czech Republic.
700    1_
$a Ripova, Daniela $u Department of Biochemistry and Brain Pathophysiology, National Institute of Mental Health, Topolova 748, Klecany, 250 67, Czech Republic.
700    1_
$a LeRoith, Derek, $u Department of Medicine, Icahn School of Medicine at Mt Sinai, New York, NY, 10029, USA. $d 1945- $7 nlk20060173284
700    1_
$a Schnaider-Beeri, Michal $u The Joseph Sagol Neuroscience Center Tel Hashomer, Ramat Gan, 52621, Israel. Department of Psychiatry, Mount Sinai School of Medicine, New York, NY, 10029, USA.
773    0_
$w MED00007638 $t Aging cell $x 1474-9726 $g Roč. 15, č. 2 (2016), s. 309-16
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26781037 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20240502090317 $b ABA008
999    __
$a ok $b bmc $g 1200617 $s 974930
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 15 $c 2 $d 309-16 $e 20160119 $i 1474-9726 $m Aging cell $n Aging cell $x MED00007638
LZP    __
$a Pubmed-20170413

Find record

Citation metrics

Archiving options